Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In a randomized, double-blinded, placebo-controlled clinical phase III prevention trial, identified as NCT02921217 - Bifidobacterium animalis lactis BPL1 vs Bifidobacterium animalis lactis BPL1 inactivated & Adiposity / Obesity, it was discovered that individuals with abdominal obesity experienced improvements in anthropometric adiposity biomarkers when consuming Bifidobacterium animalis lactis BPL1. This was true whether the probiotic was in its viable form or primarily as Bifidobacterium animalis lactis BPL1 inactivated, with notable effects …